Project Details
| Short title | 22676 |
|---|---|
| Status | Finished |
| Effective start/end date | 10/10/24 → 23/09/25 |
CTU: Phase 1 study of a SOS1 inhibitor, BAY 3498264, in combination in participants with advanced KRASG12C-mutated solid tumors
- Park, John (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- McHugh, Tracey (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research